Radio-frequency ablation of VX2 rabbit tumors: Assessment of completeness of treatment by using contrast-enhanced harmonic power doppler US

Radiology

Volumn 225, Issue 3, 2002, Pages 815-821

  Boehm, Thomas ^a   Malich, Ansgar ^b   Goldberg, S Nahum ^c   Hauff, Peter ^c,d   Reinhardt, Michael ^c,d   Reichenbach, Juergen R ^b   Müller, Wolfgang ^e   Fleck, Marlies ^b   Seifert, Burkhardt ^f   Kaiser, Werner A ^b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^c HARVARD MEDICAL SCHOOL   (United States)

^d BAYER PHARMA AG   (Germany)

^e Berchtold GmbH   (Germany)

^f UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Animals; Radiofrequency (RF) ablation; Ultrasound (US), comparative studies; Ultrasound (US), experimental studies; Ultrasound (US), harmonic study

Indexed keywords

SHU 508; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; BREAST TUMOR; CANCER GRAFT; CATHETER ABLATION; COLOR ULTRASOUND FLOWMETRY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; FOLLOW UP; HISTOPATHOLOGY; MINIMAL RESIDUAL DISEASE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RETROPERITONEUM; TUMOR NECROSIS; TUMOR RECURRENCE; TUMOR VASCULARIZATION; TUMOR VOLUME;

EID: 0036893471     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2253011564     Document Type: Article

References (44)

1. McGahan JP, Schneider P, Brock JM, Tesluk H. Treatment of liver tumors by percutaneous radiofrequency electrocautery. Semin Intervent Radiol 1993; 10: 143-149.
2. Solbiati L, Ierace T, Goldberg SN, et al. Percutaneous US-guided radio-frequency tissue ablation of liver metastasis: Treatment and follow up in 16 patients. Radiology 1997; 202:195-203.
3. McGahan JP, Browning PD, Brock JM, Tesluk H. Hepatic ablation using radiofrequency electrocautery. Invest Radiol 1990; 25:267-270.
4. Mostafid AH, Harrison NW, Thomas PJ, Fletcher MS. A prospective randomized trial of interstitial radiofrequency therapy versus transurethral resection for the treatment of benign prostatic hyperplasia. Br J Urol 1997; 80:116-122.
5. Zlotta AR, Raviv G, Peny MO, Noel JC, Haot J, Schulman CC. Possible mechanisms of action of transurethral needle ablation of the prostate on benign prostatic hyperplasia symptoms: A neurohistochemical study. J Urol 1997; 157:894-899.
6. Zlotta AR, Wildschutz T, Raviv G, et al. Radiofrequency interstitial tumor ablation (RITA) is a possible new modality for treatment of renal cancer: Ex vivo and in vivo experience. J Endourol 1997; 11:251-258.
7. Rosenthal DI, Alexander A, Rosenberg AE, Springfield D. Ablation of osteoid osteomas with a percutaneously placed electrode: A new procedure. Radiology 1992; 183:29-33.
8. Rosenthal DI, Springfield DS, Gebhardt MC, Rosenberg AE, Mankin HJ. Osteoid osteoma: Percutaneous radio-frequency ablation. Radiology 1995; 197:451-454.
9. Cosman ER, Nashold BS, Bedenbaugh P. Stereotactic radiofrequency lesion making. Appl Neurophysiol 1983; 46:160-166.
10. Farahani K, Mischel PS, Black KL, De Salles AA, Anzai Y, Lufkin RB. Hyperacute thermal lesions: MR imaging evaluation of development in the brain. Radiology 1995; 196:517-520.
11. Dupuy DE, Zagoria RJ, Akerley W, MayoSmith WW, Kavanagh PV, Safran H. Percutaneous radiofrequency ablation of malignancies in the lung. AJR Am J Roentgenol 2000; 174:57-59.
12. Goldberg SN, Gazelle GS, Compton CC, McLoud TC. Radiofrequency tissue ablation in the rabbit lung: Efficacy and complications. Acad Radiol 1995; 2:776-784.
13. Buscarini L, Buscarini E, Di Stasi M, Vallisa D, Quaretti P, Rocca A. Percutaneous radiofrequency ablation of small hepatocellular carcinoma: Long-term results. Eur Radiol 2001; 11:914-921.
14. Iannitti DA, Dupuy DE. Minimally invasive management of hepatic metastases. Semin Laparosc Surg 2000; 7:118-128.
15. Solbiati L, Ierace T, Tonolini M, Osti V, Cova L. Radiofrequency thermal ablation of hepatic metastases. Eur J Ultrasound 2001; 13:149-158.
16. Hellriegel KP. Brusterhaltende therapie beim mammakarzinom: indikation und konsequenzen - Ergebnisse einer multidisziplinaren konsensus-tagung. Handchir Mikrochir Plast Chir 1991; 23:96-99; discussion 99-101.
17. Fisher B, Redmont C, Poisson R. Eight-year result of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the therapy of breast cancer. N Engl J Med 1989; 320: 822-828.
18. Kiebert GM, de Haes JC, van de Velde CJ. The impact of breast-conserving treatment and mastectomy on the quality of life of early-stage breast cancer patients: a review. J Clin Oncol 1991; 9:1059-1070.
19. Harari PM, Hynynen KH, Roemer RB, et al. Development of scanned focussed ultrasound hyperthermia: Clinical response evaluation. Int J Radiat Oncol Biol Phys 1991; 21:831-840.
20. Harries SA, Amin Z, Smith ME, et al. Interstitial laser photocoagulation as a treatment for breast cancer. Br J Surg 1994; 81:1617-1619.
21. Hall-Craggs MA. MR-guidance of laser therapy to breast neoplasmas. Presented at the 4th International Symposium on Interventional MRI, Düsseldorf, Germany, September 25, 1997.
22. Jeffrey SS, Birdwell RL, Ikeda DM, et al. Radiofrequency ablation of breast cancer: First report of an emerging technology. Arch Surg 1999; 134:1064-1068.
23. Rand RW, Rand RP, Eggerding F, DenBesten L, King W. Cryolumpectomy for carcinoma of the breast. Surg Gynecol Obstet 1987; 165:392-396.
24. Staren DE, Sabel MS, Gianakakis LM, et al. Cryosurgery of breast cancer. Arch Surg 1997; 132:28-33.
25. Böhm T, Hilger I, Mueller W, Reichenbach JR, Fleck M, Kaiser WA. Saline enhanced radiofrequency ablation of breast tissue: An in-vitro feasibility study. Invest Radiol 2000; 35:149-157.
26. Rossi S, Di Stasi M, Buscarini E, et al., Percutanous radiofrequency interstitial thermal ablation in the treatment of small hepatocellular carcinoma. Cancer J 1995; 1:73-81.
27. Garbagnati F, Lanocita R, DiTolla G, Patelli G, Uslenghi E, Rossi S. Contrast power Doppler ultrasound in immediate evaluation of small hepatocellular carcinoma radiofrequency treatment (abstr). Radiology 1998; 209(P):266.
28. Schwarz KQ, Chen XC, Steinmetz S, Phillips D. Harmonic imaging with Levovist. J Am Soc Echocardiogr 1997; 10:1-10.
29. Hauff P, Fritzsch T, Reinhardt M, et al. Delineation of experimental liver tumors in rabbits by a new ultrasound contrast agent and stimulated acoustic emission. Invest Radiol 1997; 32:94-99.
30. Boehm T, Malich A, Reichenbach JR, Fleck M, Kaiser WA. Percutaneous radiofrequency (RF) thermal ablation of rabbit tumors embedded in fat: A model for RF ablation of breast tumors. Invest Radiol 2001; 36:480-486.
31. Soderstrom CE, Harms SE, Copit DS, et al. Three-dimensional RODEO breast MR imaging of lesions containing ductal carcinoma in situ. Radiology 1996; 201:427-432.
32. Viehweg P, Lampe D, Buchmann J, Heywang-Kobrunner SH. In situ and minimally invasive breast cancer: Morphologic and kinetic features on contrast-enhanced MR imaging. MAGMA 2000; 11:129-137.
33. Boehm T, Malich A, Goldberg SN, et al. Vacuum assisted resection of malignant tumors with and without subsequent radiofrequency ablation: Feasibility of complete tumor treatment tested in an animal model. J Vasc Interv Radiol 2001; 12:1086-1093.
34. Steiner P, Botnar R, Goldberg SN, Gazelle GS, Debatin JF. Monitoring of radio frequency tissue ablation in an interventional magnetic resonance environment: Preliminary ex vivo and in vivo results. Invest Radiol 1997; 32:671-678.
35. Chung YC, Duerk JL, Lewin JS. Generation and observation of radio frequency thermal lesion ablation for interventional magnetic resonance imaging. Invest Radiol 1997; 32:466-474.
36. Munck JN, Riggi M, Rougier P, et al. Pharmacokinetic and pharmacodynamic advantages of pirarubicin over adriamycin after intraarterial hepatic administration in the rabbit VX2 tumor model. Cancer Res 1993; 53:1550-1554.
37. Neumann RA, Knobler RM, Pieczkowski F, Gebhart W. Enzyme histochemical analysis of cell viability after argon laserinduced coagulation necrosis of the skin. J Am Acad Dermatol 1991; 25:991-998.
38. Neumann RA, Leonhartsberger H, Pieczkowski F, Knobler RM, Gebhart W. Accurate histochemical definition of argon-laser-induced tissue necrosis. Dermatology 1992; 184:202-204.
39. Sträuli P, Haemmerli G. The V2 carcinoma of the rabbit as an integrated model of tumor invasion. Bull Cancer (Paris) 1984; 71:447-452.
40. Goldberg SN, Hahn PF, Tanabe KK, et al. Percutaneous radiofrequency tissue ablation: Does perfusion-mediated tissue cooling limit coagulation necrosis? J Vasc Interv Radiol 1998; 9:1-11.
41. Solbiati L, Arsizio B, Goldberg SN, et al. Microbubble ultrasound contrast agents: A useful adjunct for radiofrequency tumor ablation (abstr). Radiology 1997; 205(P):367.
42. Goldberg SN, Walovitch RC, Straub JA, Shore MT, Gazelle GS. Radio-frequencyinduced coagulation necrosis in rabbits: Immediate detection at US with a synthetic microsphere contrast agent. Radiology 1999; 213:438-444.
43. Boehm T, Malich A, Goldberg SN, et al. Radio-frequency tumor ablation: Internally cooled electrode versus saline-enhanced technique in a highly aggressive animal tumor model in the rabbit. Radiology 2002; 222:805-813.
44. Sittek H, Linsmeier E, Perlet C, et al. Preoperative marking and biopsy of nonpalpable breast lesions with a guidance system for the open Magnetom. Radiologe 2000; 40:1098-1105. [German]